Colleen Julian
Concepts (368)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Altitude | 49 | 2023 | 422 | 8.270 |
Why?
| Pre-Eclampsia | 13 | 2023 | 183 | 3.580 |
Why?
| Hypoxia | 24 | 2023 | 963 | 3.210 |
Why?
| Placenta | 10 | 2023 | 639 | 3.200 |
Why?
| Fetal Growth Retardation | 19 | 2023 | 468 | 2.810 |
Why?
| Fetal Hypoxia | 7 | 2022 | 46 | 2.650 |
Why?
| Altitude Sickness | 15 | 2022 | 163 | 2.610 |
Why?
| Uterine Artery | 13 | 2022 | 65 | 2.250 |
Why?
| Adaptation, Physiological | 12 | 2021 | 502 | 2.180 |
Why?
| Pregnancy | 52 | 2023 | 5691 | 2.150 |
Why?
| Acclimatization | 13 | 2019 | 135 | 2.070 |
Why?
| PPAR gamma | 3 | 2020 | 188 | 1.710 |
Why?
| Oxygen | 16 | 2023 | 854 | 1.610 |
Why?
| Birth Weight | 12 | 2019 | 465 | 1.490 |
Why?
| Placental Circulation | 6 | 2022 | 56 | 1.400 |
Why?
| AMP-Activated Protein Kinases | 6 | 2023 | 178 | 1.200 |
Why?
| Hypertension, Pregnancy-Induced | 5 | 2023 | 46 | 1.090 |
Why?
| Pregnancy Outcome | 4 | 2019 | 349 | 1.090 |
Why?
| Selection, Genetic | 7 | 2019 | 252 | 1.070 |
Why?
| Pregnancy Complications | 4 | 2017 | 448 | 1.040 |
Why?
| Endothelin-1 | 2 | 2020 | 168 | 0.930 |
Why?
| Biology | 1 | 2023 | 83 | 0.860 |
Why?
| Uterus | 4 | 2020 | 194 | 0.840 |
Why?
| Bolivia | 15 | 2023 | 60 | 0.810 |
Why?
| Fetal Development | 7 | 2022 | 250 | 0.770 |
Why?
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2021 | 104 | 0.740 |
Why?
| Female | 66 | 2023 | 61564 | 0.740 |
Why?
| Sympathetic Nervous System | 6 | 2020 | 171 | 0.730 |
Why?
| Hypertension, Pulmonary | 2 | 2022 | 1794 | 0.730 |
Why?
| Neovascularization, Physiologic | 1 | 2021 | 181 | 0.700 |
Why?
| Polycythemia | 3 | 2017 | 26 | 0.680 |
Why?
| Erythropoietin | 3 | 2017 | 82 | 0.650 |
Why?
| Pulmonary Circulation | 2 | 2021 | 424 | 0.610 |
Why?
| Epigenesis, Genetic | 3 | 2023 | 539 | 0.600 |
Why?
| Receptors, Erythropoietin | 1 | 2017 | 25 | 0.590 |
Why?
| Vascular Diseases | 2 | 2017 | 241 | 0.580 |
Why?
| Adult | 42 | 2021 | 31510 | 0.570 |
Why?
| Infant, Small for Gestational Age | 3 | 2011 | 73 | 0.550 |
Why?
| Humans | 72 | 2023 | 118969 | 0.530 |
Why?
| Gene Expression Regulation | 3 | 2021 | 2445 | 0.520 |
Why?
| Vascular Endothelial Growth Factor A | 3 | 2023 | 527 | 0.520 |
Why?
| Regional Blood Flow | 7 | 2015 | 418 | 0.520 |
Why?
| Enzymes | 2 | 2013 | 66 | 0.510 |
Why?
| Arteries | 3 | 2022 | 250 | 0.500 |
Why?
| Vasodilation | 4 | 2022 | 457 | 0.490 |
Why?
| Prenatal Exposure Delayed Effects | 2 | 2021 | 468 | 0.480 |
Why?
| DNA Methylation | 2 | 2023 | 503 | 0.440 |
Why?
| Sleep Apnea Syndromes | 1 | 2013 | 80 | 0.420 |
Why?
| Oxygen Consumption | 2 | 2011 | 586 | 0.410 |
Why?
| Blood Proteins | 1 | 2013 | 248 | 0.410 |
Why?
| Hemoglobins | 7 | 2017 | 326 | 0.400 |
Why?
| Antioxidants | 2 | 2013 | 564 | 0.400 |
Why?
| Infant, Low Birth Weight | 2 | 2011 | 125 | 0.400 |
Why?
| Signal Transduction | 3 | 2021 | 4709 | 0.400 |
Why?
| Erythrocytes | 4 | 2017 | 641 | 0.400 |
Why?
| Case-Control Studies | 8 | 2017 | 3171 | 0.390 |
Why?
| Cell Membrane Permeability | 1 | 2011 | 88 | 0.390 |
Why?
| Infant, Newborn | 12 | 2022 | 5255 | 0.380 |
Why?
| Erythropoiesis | 2 | 2014 | 33 | 0.370 |
Why?
| Placental Insufficiency | 2 | 2023 | 104 | 0.360 |
Why?
| Biological Evolution | 2 | 2015 | 443 | 0.360 |
Why?
| Gestational Age | 9 | 2021 | 765 | 0.360 |
Why?
| Oxidative Stress | 2 | 2013 | 1178 | 0.350 |
Why?
| Young Adult | 18 | 2020 | 10793 | 0.340 |
Why?
| Lung Diseases | 1 | 2015 | 718 | 0.340 |
Why?
| Polymorphism, Single Nucleotide | 8 | 2019 | 2062 | 0.340 |
Why?
| Women's Health | 1 | 2011 | 274 | 0.340 |
Why?
| Fertility | 1 | 2009 | 135 | 0.330 |
Why?
| Lung | 1 | 2021 | 3664 | 0.320 |
Why?
| Proteomics | 1 | 2013 | 876 | 0.310 |
Why?
| Hemodynamics | 3 | 2021 | 1004 | 0.300 |
Why?
| Cerebrovascular Circulation | 3 | 2013 | 204 | 0.290 |
Why?
| Receptor, Adenosine A2B | 2 | 2017 | 32 | 0.290 |
Why?
| Hypertension | 1 | 2015 | 1203 | 0.290 |
Why?
| Maternal-Fetal Exchange | 2 | 2021 | 157 | 0.280 |
Why?
| Disease Models, Animal | 3 | 2021 | 3730 | 0.280 |
Why?
| Nitric Oxide | 2 | 2020 | 892 | 0.250 |
Why?
| Animals | 12 | 2023 | 33381 | 0.250 |
Why?
| Mice, Inbred C57BL | 5 | 2021 | 4908 | 0.240 |
Why?
| Placenta Growth Factor | 2 | 2022 | 25 | 0.240 |
Why?
| HELLP Syndrome | 1 | 2023 | 6 | 0.240 |
Why?
| Physical Education and Training | 1 | 2003 | 62 | 0.240 |
Why?
| Blood Pressure | 7 | 2020 | 1664 | 0.240 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2022 | 67 | 0.230 |
Why?
| Muscle, Skeletal | 5 | 2023 | 1515 | 0.230 |
Why?
| Phenylephrine | 2 | 2020 | 85 | 0.230 |
Why?
| Mice | 7 | 2021 | 15520 | 0.220 |
Why?
| Ion Channels | 1 | 2023 | 126 | 0.220 |
Why?
| Male | 19 | 2019 | 57800 | 0.220 |
Why?
| Amino Acids | 3 | 2023 | 465 | 0.220 |
Why?
| Task Performance and Analysis | 1 | 2003 | 164 | 0.220 |
Why?
| Phenotype | 2 | 2023 | 3003 | 0.220 |
Why?
| Longitudinal Studies | 3 | 2019 | 2513 | 0.220 |
Why?
| Baroreflex | 3 | 2020 | 53 | 0.220 |
Why?
| Geography | 3 | 2011 | 190 | 0.220 |
Why?
| Vascular Endothelial Growth Factors | 1 | 2022 | 67 | 0.210 |
Why?
| Cesarean Section | 1 | 2023 | 165 | 0.210 |
Why?
| Arterial Pressure | 3 | 2020 | 99 | 0.200 |
Why?
| Biomarkers | 4 | 2017 | 3588 | 0.200 |
Why?
| Acute Disease | 3 | 2013 | 940 | 0.200 |
Why?
| Acetazolamide | 2 | 2011 | 28 | 0.200 |
Why?
| Running | 1 | 2003 | 227 | 0.200 |
Why?
| Frailty | 1 | 2023 | 116 | 0.200 |
Why?
| Ventricular Pressure | 1 | 2021 | 41 | 0.200 |
Why?
| Pedigree | 2 | 2020 | 485 | 0.190 |
Why?
| Hyperbaric Oxygenation | 1 | 2021 | 39 | 0.190 |
Why?
| Phosphorylation | 3 | 2021 | 1633 | 0.190 |
Why?
| Mammals | 1 | 2022 | 253 | 0.190 |
Why?
| Blood Volume | 3 | 2017 | 58 | 0.190 |
Why?
| Inflammation | 1 | 2011 | 2566 | 0.190 |
Why?
| Europe | 4 | 2009 | 356 | 0.180 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2020 | 14 | 0.180 |
Why?
| Genomics | 2 | 2023 | 706 | 0.180 |
Why?
| Myometrium | 1 | 2020 | 35 | 0.180 |
Why?
| Geographic Mapping | 1 | 2019 | 21 | 0.180 |
Why?
| Abortion, Spontaneous | 1 | 2020 | 94 | 0.180 |
Why?
| Vascular Resistance | 4 | 2020 | 356 | 0.180 |
Why?
| Pulmonary Artery | 2 | 2015 | 1063 | 0.170 |
Why?
| Hypoxia-Inducible Factor-Proline Dioxygenases | 2 | 2017 | 20 | 0.170 |
Why?
| Dexamethasone | 2 | 2011 | 320 | 0.170 |
Why?
| Thiazolidinediones | 1 | 2020 | 146 | 0.170 |
Why?
| Genetics, Population | 2 | 2010 | 207 | 0.170 |
Why?
| Ventricular Function, Right | 1 | 2021 | 257 | 0.170 |
Why?
| Nitric Oxide Synthase | 1 | 2019 | 225 | 0.160 |
Why?
| Adenosine | 2 | 2017 | 211 | 0.160 |
Why?
| Protein Kinases | 1 | 2020 | 310 | 0.160 |
Why?
| Fetus | 3 | 2023 | 690 | 0.160 |
Why?
| Gene Expression | 1 | 2023 | 1489 | 0.160 |
Why?
| Trophoblasts | 1 | 2019 | 170 | 0.160 |
Why?
| Peroneal Nerve | 1 | 2017 | 19 | 0.160 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2021 | 394 | 0.160 |
Why?
| Maternal Health Services | 1 | 2019 | 83 | 0.160 |
Why?
| Time Factors | 5 | 2017 | 6412 | 0.150 |
Why?
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2017 | 219 | 0.150 |
Why?
| Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 12 | 0.150 |
Why?
| Middle Cerebral Artery | 2 | 2013 | 30 | 0.150 |
Why?
| Cell Cycle Proteins | 1 | 2021 | 565 | 0.150 |
Why?
| Epigenomics | 1 | 2017 | 107 | 0.150 |
Why?
| Colorado | 3 | 2019 | 4196 | 0.140 |
Why?
| Heart Rate | 5 | 2020 | 729 | 0.140 |
Why?
| Sphingosine | 1 | 2016 | 35 | 0.140 |
Why?
| Muscle, Smooth, Vascular | 1 | 2019 | 454 | 0.140 |
Why?
| Cardiovascular System | 1 | 2017 | 127 | 0.140 |
Why?
| Lysophospholipids | 1 | 2016 | 68 | 0.140 |
Why?
| Autonomic Pathways | 1 | 2015 | 2 | 0.140 |
Why?
| Double-Blind Method | 3 | 2011 | 1687 | 0.130 |
Why?
| Immunohistochemistry | 1 | 2020 | 1691 | 0.130 |
Why?
| California | 1 | 2017 | 382 | 0.130 |
Why?
| Pulmonary Gas Exchange | 1 | 2015 | 117 | 0.130 |
Why?
| Pulmonary Veins | 1 | 2015 | 84 | 0.130 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 827 | 0.120 |
Why?
| Receptor, Endothelin A | 1 | 2014 | 60 | 0.120 |
Why?
| Diabetes, Gestational | 1 | 2018 | 284 | 0.120 |
Why?
| Aromatase | 1 | 2014 | 31 | 0.120 |
Why?
| Muscles | 1 | 2015 | 333 | 0.120 |
Why?
| Biological Transport | 2 | 2019 | 382 | 0.120 |
Why?
| Parity | 3 | 2018 | 101 | 0.120 |
Why?
| Incidence | 2 | 2018 | 2424 | 0.120 |
Why?
| Homeostasis | 2 | 2014 | 594 | 0.120 |
Why?
| Prospective Studies | 3 | 2022 | 6471 | 0.120 |
Why?
| Tibet | 4 | 2017 | 28 | 0.120 |
Why?
| Congenital Abnormalities | 2 | 1991 | 74 | 0.110 |
Why?
| Ultrasonography, Doppler | 3 | 2020 | 104 | 0.110 |
Why?
| Leukocytes, Mononuclear | 1 | 2015 | 509 | 0.110 |
Why?
| Glycolysis | 3 | 2021 | 224 | 0.110 |
Why?
| Delivery, Obstetric | 2 | 2011 | 125 | 0.110 |
Why?
| Health Services Accessibility | 1 | 2019 | 781 | 0.110 |
Why?
| Body Height | 1 | 2013 | 187 | 0.110 |
Why?
| Endothelium, Vascular | 1 | 2019 | 907 | 0.110 |
Why?
| Polysomnography | 1 | 2013 | 157 | 0.110 |
Why?
| Regression Analysis | 3 | 2018 | 983 | 0.110 |
Why?
| Risk Factors | 6 | 2019 | 8999 | 0.110 |
Why?
| Prenatal Diagnosis | 2 | 1991 | 168 | 0.110 |
Why?
| Healthy Volunteers | 3 | 2017 | 201 | 0.100 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2013 | 490 | 0.100 |
Why?
| Apgar Score | 1 | 2011 | 16 | 0.100 |
Why?
| Carbonic Anhydrase Inhibitors | 1 | 2011 | 18 | 0.100 |
Why?
| Hypoxia, Brain | 1 | 2011 | 8 | 0.100 |
Why?
| Tandem Mass Spectrometry | 1 | 2013 | 421 | 0.100 |
Why?
| Estrogens | 1 | 2014 | 328 | 0.100 |
Why?
| Respiratory Physiological Phenomena | 1 | 2011 | 31 | 0.100 |
Why?
| Respiratory Function Tests | 1 | 2013 | 526 | 0.100 |
Why?
| Mountaineering | 1 | 2011 | 47 | 0.100 |
Why?
| Brain Edema | 1 | 2011 | 61 | 0.100 |
Why?
| Cross-Sectional Studies | 3 | 2017 | 4552 | 0.100 |
Why?
| Angiostatic Proteins | 1 | 2010 | 5 | 0.100 |
Why?
| Follow-Up Studies | 2 | 2017 | 4596 | 0.100 |
Why?
| Lactic Acid | 2 | 2023 | 282 | 0.090 |
Why?
| Oxidation-Reduction | 1 | 2013 | 940 | 0.090 |
Why?
| Angiogenic Proteins | 1 | 2010 | 21 | 0.090 |
Why?
| Blood-Brain Barrier | 1 | 2011 | 108 | 0.090 |
Why?
| Retrospective Studies | 4 | 2022 | 12975 | 0.090 |
Why?
| Confidence Intervals | 1 | 2011 | 324 | 0.090 |
Why?
| Headache | 1 | 2011 | 128 | 0.090 |
Why?
| Anthropology, Physical | 1 | 2009 | 29 | 0.090 |
Why?
| Sheep | 2 | 2023 | 764 | 0.090 |
Why?
| Fetal Diseases | 1 | 1991 | 148 | 0.090 |
Why?
| Cohort Studies | 3 | 2020 | 5115 | 0.090 |
Why?
| HIV Infections | 1 | 2023 | 2459 | 0.090 |
Why?
| Fetal Blood | 1 | 2011 | 272 | 0.090 |
Why?
| Databases, Genetic | 1 | 2010 | 253 | 0.080 |
Why?
| Prognosis | 1 | 2017 | 3443 | 0.080 |
Why?
| South America | 3 | 2014 | 56 | 0.080 |
Why?
| Up-Regulation | 1 | 2011 | 872 | 0.080 |
Why?
| Genome, Human | 1 | 2010 | 387 | 0.080 |
Why?
| Interleukin-1beta | 1 | 2010 | 379 | 0.080 |
Why?
| Adolescent | 3 | 2019 | 18479 | 0.080 |
Why?
| Chronic Disease | 1 | 2013 | 1636 | 0.080 |
Why?
| Head | 1 | 2008 | 89 | 0.080 |
Why?
| Anti-Inflammatory Agents | 1 | 2011 | 465 | 0.080 |
Why?
| Urban Health | 1 | 2007 | 78 | 0.070 |
Why?
| Rest | 2 | 2019 | 104 | 0.070 |
Why?
| Femur | 1 | 2008 | 199 | 0.070 |
Why?
| GPI-Linked Proteins | 2 | 2017 | 56 | 0.070 |
Why?
| 5'-Nucleotidase | 2 | 2017 | 34 | 0.070 |
Why?
| 2,3-Diphosphoglycerate | 2 | 2016 | 29 | 0.070 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2007 | 70 | 0.070 |
Why?
| Indians, South American | 3 | 2013 | 23 | 0.070 |
Why?
| Health Status | 1 | 2011 | 726 | 0.070 |
Why?
| Blood Flow Velocity | 3 | 2013 | 327 | 0.070 |
Why?
| Ultrasonography, Prenatal | 3 | 2013 | 227 | 0.070 |
Why?
| Cold Temperature | 2 | 2017 | 132 | 0.070 |
Why?
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 101 | 0.070 |
Why?
| Down Syndrome | 1 | 1991 | 356 | 0.070 |
Why?
| Haplotypes | 2 | 2017 | 473 | 0.070 |
Why?
| Mental Health | 1 | 2011 | 568 | 0.070 |
Why?
| Maternal Age | 2 | 2018 | 122 | 0.060 |
Why?
| Reticulocyte Count | 1 | 2003 | 5 | 0.060 |
Why?
| Receptors, Transferrin | 1 | 2003 | 23 | 0.060 |
Why?
| Indians, North American | 1 | 2009 | 598 | 0.060 |
Why?
| Chi-Square Distribution | 2 | 2018 | 525 | 0.060 |
Why?
| Age Factors | 1 | 2011 | 2995 | 0.060 |
Why?
| Surveys and Questionnaires | 3 | 2013 | 4708 | 0.060 |
Why?
| Gene Expression Profiling | 1 | 2010 | 1597 | 0.060 |
Why?
| Pyruvates | 1 | 2023 | 20 | 0.060 |
Why?
| Solubility | 1 | 2003 | 235 | 0.060 |
Why?
| Glutamine | 1 | 2023 | 88 | 0.060 |
Why?
| Serine | 1 | 2023 | 138 | 0.050 |
Why?
| Cytokines | 1 | 2010 | 1900 | 0.050 |
Why?
| Body Weight | 1 | 2007 | 934 | 0.050 |
Why?
| Glycine | 1 | 2023 | 162 | 0.050 |
Why?
| Potassium Channels | 1 | 2022 | 123 | 0.050 |
Why?
| Developing Countries | 1 | 2023 | 255 | 0.050 |
Why?
| Gene Frequency | 2 | 2014 | 513 | 0.050 |
Why?
| Pyruvic Acid | 1 | 2021 | 48 | 0.050 |
Why?
| Blood Gas Analysis | 2 | 2014 | 69 | 0.050 |
Why?
| Pregnancy Trimester, Third | 2 | 2019 | 69 | 0.050 |
Why?
| Amniocentesis | 2 | 1991 | 24 | 0.050 |
Why?
| Pyrones | 1 | 2020 | 9 | 0.050 |
Why?
| Aminoimidazole Carboxamide | 1 | 2020 | 11 | 0.050 |
Why?
| Ribonucleotides | 1 | 2020 | 26 | 0.050 |
Why?
| Adenosine Triphosphate | 1 | 2022 | 439 | 0.050 |
Why?
| Mice, Knockout | 2 | 2017 | 2680 | 0.050 |
Why?
| Biphenyl Compounds | 1 | 2020 | 52 | 0.050 |
Why?
| Thiophenes | 1 | 2020 | 106 | 0.040 |
Why?
| Vasoconstrictor Agents | 1 | 2020 | 122 | 0.040 |
Why?
| Acetylcholine | 1 | 2020 | 208 | 0.040 |
Why?
| Vasodilator Agents | 1 | 2020 | 328 | 0.040 |
Why?
| Glucose | 1 | 2023 | 953 | 0.040 |
Why?
| Evoked Potentials, Motor | 1 | 2017 | 37 | 0.040 |
Why?
| Renin | 1 | 2017 | 35 | 0.040 |
Why?
| Arginine Vasopressin | 1 | 2017 | 47 | 0.040 |
Why?
| Recruitment, Neurophysiological | 1 | 2017 | 35 | 0.040 |
Why?
| Aldosterone | 1 | 2017 | 43 | 0.040 |
Why?
| Ultrasonography | 2 | 2014 | 716 | 0.040 |
Why?
| Genome-Wide Association Study | 2 | 2017 | 1323 | 0.040 |
Why?
| Genotype | 2 | 2014 | 1882 | 0.040 |
Why?
| Osmolar Concentration | 1 | 2017 | 185 | 0.040 |
Why?
| Ferritins | 1 | 2017 | 61 | 0.040 |
Why?
| Bisphosphoglycerate Mutase | 1 | 2016 | 6 | 0.040 |
Why?
| Ubiquitination | 1 | 2017 | 87 | 0.040 |
Why?
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2016 | 5 | 0.040 |
Why?
| Pentose Phosphate Pathway | 1 | 2016 | 44 | 0.040 |
Why?
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 42 | 0.040 |
Why?
| Sulfur | 1 | 2016 | 44 | 0.040 |
Why?
| Posture | 1 | 2017 | 158 | 0.040 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 140 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2016 | 280 | 0.030 |
Why?
| Purines | 1 | 2016 | 161 | 0.030 |
Why?
| Arginine | 1 | 2016 | 249 | 0.030 |
Why?
| Gene-Environment Interaction | 1 | 2017 | 201 | 0.030 |
Why?
| Diastole | 1 | 2015 | 145 | 0.030 |
Why?
| Glutathione | 1 | 2016 | 324 | 0.030 |
Why?
| Vagus Nerve | 1 | 2015 | 80 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2018 | 1474 | 0.030 |
Why?
| Action Potentials | 1 | 2017 | 420 | 0.030 |
Why?
| Receptor, Endothelin B | 1 | 2014 | 53 | 0.030 |
Why?
| Receptors, Endothelin | 1 | 2014 | 49 | 0.030 |
Why?
| Enzyme Activation | 1 | 2016 | 828 | 0.030 |
Why?
| Infant | 2 | 2020 | 8293 | 0.030 |
Why?
| Ultrasonography, Doppler, Transcranial | 1 | 2013 | 35 | 0.030 |
Why?
| Protein Processing, Post-Translational | 1 | 2016 | 408 | 0.030 |
Why?
| Evaluation Studies as Topic | 2 | 1991 | 182 | 0.030 |
Why?
| Body Weights and Measures | 1 | 2013 | 35 | 0.030 |
Why?
| Aging | 1 | 2023 | 1670 | 0.030 |
Why?
| Metabolome | 1 | 2016 | 296 | 0.030 |
Why?
| Radial Artery | 1 | 2013 | 74 | 0.030 |
Why?
| Exercise | 1 | 2023 | 1657 | 0.030 |
Why?
| Acute Lung Injury | 1 | 2016 | 310 | 0.030 |
Why?
| Gonadal Steroid Hormones | 1 | 2014 | 122 | 0.030 |
Why?
| Gene Regulatory Networks | 1 | 2014 | 239 | 0.030 |
Why?
| Aged | 2 | 2023 | 19656 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2014 | 371 | 0.030 |
Why?
| Prevalence | 1 | 2018 | 2326 | 0.030 |
Why?
| Obstetric Labor, Premature | 1 | 1992 | 38 | 0.030 |
Why?
| Child | 1 | 2011 | 19129 | 0.030 |
Why?
| Linear Models | 1 | 2014 | 827 | 0.030 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2014 | 369 | 0.030 |
Why?
| Pregnancy, High-Risk | 1 | 1991 | 12 | 0.020 |
Why?
| Exercise Test | 1 | 2014 | 551 | 0.020 |
Why?
| Laser-Doppler Flowmetry | 1 | 2011 | 33 | 0.020 |
Why?
| Live Birth | 1 | 2011 | 47 | 0.020 |
Why?
| Iliac Artery | 1 | 2011 | 44 | 0.020 |
Why?
| Globins | 1 | 2010 | 22 | 0.020 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2010 | 20 | 0.020 |
Why?
| Stillbirth | 1 | 2011 | 57 | 0.020 |
Why?
| Pregnancy Proteins | 1 | 2010 | 38 | 0.020 |
Why?
| Renin-Angiotensin System | 1 | 2010 | 82 | 0.020 |
Why?
| Interleukin-4 | 1 | 2010 | 215 | 0.020 |
Why?
| DNA Copy Number Variations | 1 | 2010 | 167 | 0.020 |
Why?
| Cross-Over Studies | 1 | 2011 | 456 | 0.020 |
Why?
| Prenatal Care | 1 | 1992 | 252 | 0.020 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 256 | 0.020 |
Why?
| Anticonvulsants | 1 | 2011 | 184 | 0.020 |
Why?
| Pregnant Women | 1 | 1990 | 132 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 246 | 0.020 |
Why?
| Interleukin-10 | 1 | 2010 | 306 | 0.020 |
Why?
| Transcription, Genetic | 1 | 2014 | 1323 | 0.020 |
Why?
| Insurance, Health | 1 | 1990 | 244 | 0.020 |
Why?
| Middle Aged | 2 | 2019 | 27617 | 0.020 |
Why?
| Infant, Premature | 1 | 1992 | 480 | 0.020 |
Why?
| Analysis of Variance | 1 | 2011 | 1293 | 0.020 |
Why?
| Heart Rate, Fetal | 1 | 2007 | 22 | 0.020 |
Why?
| Models, Biological | 1 | 2015 | 1715 | 0.020 |
Why?
| Premature Birth | 1 | 2011 | 284 | 0.020 |
Why?
| Respiratory Mechanics | 1 | 2007 | 60 | 0.020 |
Why?
| Biometry | 1 | 2007 | 65 | 0.020 |
Why?
| Phylogeny | 1 | 2010 | 816 | 0.020 |
Why?
| Cognition | 1 | 2014 | 1024 | 0.020 |
Why?
| Interleukin-6 | 1 | 2010 | 688 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2017 | 6561 | 0.020 |
Why?
| Patient Selection | 1 | 1990 | 675 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 1991 | 1795 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2013 | 2674 | 0.020 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2010 | 1171 | 0.020 |
Why?
| Heart Failure | 1 | 2017 | 1968 | 0.020 |
Why?
| Patient Acceptance of Health Care | 1 | 1990 | 687 | 0.020 |
Why?
| Lower Extremity | 1 | 2007 | 335 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2010 | 2275 | 0.010 |
Why?
| France | 2 | 1992 | 35 | 0.010 |
Why?
| Risk Assessment | 1 | 2010 | 3057 | 0.010 |
Why?
| Educational Status | 2 | 1992 | 437 | 0.010 |
Why?
| Treatment Outcome | 1 | 2011 | 9342 | 0.010 |
Why?
| Hospitals, Maternity | 1 | 1992 | 4 | 0.010 |
Why?
| Fathers | 1 | 1992 | 47 | 0.010 |
Why?
| Marriage | 1 | 1992 | 109 | 0.010 |
Why?
| Occupations | 1 | 1990 | 37 | 0.010 |
Why?
| Resource Allocation | 1 | 1990 | 38 | 0.010 |
Why?
| Chromosome Disorders | 1 | 1990 | 39 | 0.010 |
Why?
| Social Values | 1 | 1990 | 38 | 0.010 |
Why?
| Personal Autonomy | 1 | 1990 | 41 | 0.010 |
Why?
| Chromosome Aberrations | 1 | 1990 | 136 | 0.010 |
Why?
| Religion | 1 | 1990 | 68 | 0.010 |
Why?
| Culture | 1 | 1990 | 129 | 0.010 |
Why?
| Pregnancy Trimester, Second | 1 | 1989 | 70 | 0.010 |
Why?
| Social Class | 1 | 1990 | 218 | 0.010 |
Why?
| Risk | 1 | 1990 | 853 | 0.000 |
Why?
| Smoking | 1 | 1992 | 1487 | 0.000 |
Why?
|
|
Julian's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|